Publication | Closed Access

Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways

InflammationSignal TransductionSignaling PathwayNlrp3-dependent Nf-κbMedicineApoptosisImmunologyRipk1/ripk3 AmelioratesCell Death MechanismsCell BiologyCell SignalingMapks Signaling PathwaysMolecular Signaling